1-6 of 6
Axel-R. Hanauske
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract 2722: An added twist: drug-mediated pan-inhibition of KDM catalysis causes selective reduction of mRNAs that encode a small subset of KDM enzymes

Hartmut Martin Hanauske-Abel, Mainul Hoque, Seema Husain, Sukhwinder Singh, Axel R. Hanauske, Patricia Soteropoulos
Journal: Cancer Research
Cancer Res (2025) 85 (8_Supplement_1): 2722.
https://doi.org/10.1158/1538-7445.AM2025-2722
Published: 21 April 2025
View articletitled, Abstract 2722: An added twist: drug-mediated pan-inhibition of KDM catalysis causes selective reduction of mRNAs that encode a small subset of KDM enzymes
Journal Articles

Abstract 2146: DNA copy number profiles associated with clinical outcome in advanced colorectal cancer patients treated with folfiri and aliri regimens

Leticia G. Leon, Godefridus J. Peters, Elisa Giovannetti, Kees Smid, Bauke Ylstra, Gerrit A. Meijer, Giuseppe Giaccone, Axel R. Hanauske
Journal: Cancer Research
Cancer Res (2010) 70 (8_Supplement): 2146.
https://doi.org/10.1158/1538-7445.AM10-2146
Published: 15 April 2010
View articletitled, Abstract 2146: DNA copy number profiles associated with clinical outcome in advanced colorectal cancer patients treated with folfiri and aliri regimens
Journal Articles

Removal of Breast Cancer Cells from Bone Marrow by in Vitro Purging with Ether Lipids and Cryopreservation

Hermann F. Dietzfelbinger, Dagmar Kühn, Monika Zafferani, Axel R. Hanauske, Johann W. Rastetter, Wolfgang E. Berdel
Journal: Cancer Research
Cancer Res (1993) 53 (16): 3747–3751.
Published: 01 August 1993
View articletitled, Removal of Breast Cancer Cells from Bone Marrow by in Vitro Purging with Ether Lipids and Cryopreservation
Open the PDF for Removal of Breast Cancer Cells from Bone Marrow by in Vitro Purging with Ether Lipids and Cryopreservation in another window
Journal Articles

Immunoreactive α Transforming Growth Factor Activity in Effusions from Cancer Patients as a Marker of Tumor Burden and Patient Prognosis

Carlos L. Arteaga, Axel R. Hanauske, Gary M. Clark, C. Kent Osborne, Parul Hazarika, Robert L. Pardue, Fermin Tio, Daniel D. Von Hoff
Journal: Cancer Research
Cancer Res (1988) 48 (17): 5023–5028.
Published: 01 September 1988
View articletitled, Immunoreactive α Transforming Growth Factor Activity in Effusions from Cancer Patients as a Marker of Tumor Burden and Patient Prognosis
Open the PDF for Immunoreactive α Transforming Growth Factor Activity in Effusions from Cancer Patients as a Marker of Tumor Burden and Patient Prognosis in another window
Journal Articles

Phase I Clinical Trial of Carbetimer

Axel-R. Hanauske, Teresa J. Melink, Glenn S. Harman, Gary M. Clark, John B. Craig, Jim M. Koeller, David H. Boldt, Beverly Kantor, Daniel L. Kisner, Gayle Orczyk, David W. Anderson, Edward Paget, Gisele A. Sarosy, Daniel D. Von Hoff
Journal: Cancer Research
Cancer Res (1988) 48 (18): 5353–5357.
Published: 01 September 1988
View articletitled, Phase I Clinical Trial of Carbetimer
Open the PDF for Phase I Clinical Trial of Carbetimer in another window
Journal Articles

Assessment of Biological Activity of Linear α-Transforming Growth Factor and Monospecific Antibodies to α-Transforming Growth Factor and Linear α-Transforming Growth Factor

Axel-R. Hanauske, Joy B. Buchok, Robert L. Pardue, Victoria A. Muggia, Daniel D. Von Hoff
Journal: Cancer Research
Cancer Res (1986) 46 (11): 5567–5570.
Published: 01 November 1986
View articletitled, Assessment of Biological Activity of Linear α-Transforming Growth Factor and Monospecific Antibodies to α-Transforming Growth Factor and Linear α-Transforming Growth Factor
Open the PDF for Assessment of Biological Activity of Linear α-Transforming Growth Factor and Monospecific Antibodies to α-Transforming Growth Factor and Linear α-Transforming Growth Factor in another window